Odyssey Health, Inc.
Income Statement
| Line Item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $37.5K | $257.2K |
| Cost of Revenue | $0 | $0 | $0 | $0 | $20.3K | $228.5K |
| Gross Profit | $0 | $0 | $0 | $0 | $17.2K | $28.7K |
| Gross Margin | — | — | — | — | 45.8% | 11.2% |
| Operating Expenses | ||||||
| Research & Development | $20.2K | $23.0M | — | — | — | — |
| SG&A Expense | $3.8M | $23.4M | $289.0K | $167.6K | $90.7K | $184.6K |
| Operating Income | $-3.8M | $-23.6M | $-420.4K | $-167.6K | $-73.6K | $-155.9K |
| Operating Margin | — | — | — | — | -196.4% | -60.6% |
| Interest Expense | $502.2K | $70.3K | $62.7K | $30.3K | $12.5K | $4.8K |
| Pretax Income | — | — | — | — | — | — |
| Income Tax Expense | $0 | $0 | — | — | — | — |
| Net Income | $-4.3M | $-23.4M | $-483.1K | $-197.8K | $-86.1K | $-160.7K |
| Net Margin | — | — | — | — | -229.9% | -62.5% |
| EPS (Basic) | $-0.05 | $-0.34 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | — | — | — | — | — | — |
| Shares Outstanding (Basic) | 87.1M | 69.9M | 117.1M | 114.8M | 114.8M | 114.8M |
| Shares Outstanding (Diluted) | 87.1M | 69.9M | 117.1M | 114.8M | 114.8M | 114.8M |
| Dividends Per Share | — | — | — | — | — | — |